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Objectives. This study sought to evaluate the clinical, proce-
dural, preinterventional and postinterventional quantitative cor-
onary angiographic (QCA) and intravascular ultrasound (IVUS)
predictors of restenosis after Palmaz-Schatz stent placement.
Background. Although Palmaz-Schatz stent placement reduces
restenosis compared with balloon angioplasty, in-stent restenosis
remains a major clinical problem.
Methods. QCA and IVUS studies were performed before and
after intervention (after stent placement and high pressure ad-
junct balloon angioplasty) in 382 lesions in 291 patients treated
with 476 Palmaz-Schatz stents for whom follow-up QCA data were
available 5.5 6 4.8 months (mean 6 SD) later. Univariate and
multivariate predictors of QCA restenosis (>250% diameter ste-
nosis at follow-up, follow-up percent diameter stenosis [DS] and
follow-up minimal lumen diameter [MLD]) were determined.
Results. Three variables were the most consistent predictors of
the follow-up angiographic findings: ostial lesion location, IVUS
preinterventional lesion site plaque burden (plaque/total arterial
area) and IVUS assessment of final lumen dimensions (whether
final lumen area or final MLD). All three variables predicted both
the primary (binary restenosis) and secondary (follow-up MLD
and follow-up DS) end points. In addition, a number of variables
predicted one or more but not all the end points: 1) restenosis
(IVUS preinterventional lumen and arterial area); 2) follow-up
DS (QCA lesion length); and 3) follow-up MLD (QCA lesion
length and preinterventional MLD and DS and IVUS preinter-
ventional lumen and arterial area).
Conclusions. Ostial lesion location and IVUS preinterventional
plaque burden and postinterventional lumen dimensions were the
most consistent predictors of angiographic in-stent restenosis.
(J Am Coll Cardiol 1998;31:43–9)
©1998 by the American College of Cardiology
Palmaz-Schatz stents have been shown to improve procedural
outcomes (1,2) and to reduce restenosis rates compared with
balloon angioplasty (3,4). The risk of subacute stent thrombo-
sis has been minimized by using better stent deployment
techniques and aggressive antiplatelet therapy (5,6). However,
restenosis rates of 20% to 30% after stenting (7) continue to be
a significant limitation, especially since the treatment of in-
stent restenosis (especially diffuse in-stent restenosis) remains
unsatisfactory (8,9).
Risk factors for restenosis after balloon and nonstent new
device angioplasty have been identified. However, the mecha-
nism of restenosis is different for stented versus nonstented
lesions (10–12). Thus, geometric factors important for devel-
opment of restenosis after balloon and nonstent new device
angioplasty might be of little importance in stented lesions.
The object of the present study was to evaluate the clinical,
procedural, preinterventional and postinterventional quantita-
tive coronary angiographic (QCA) and intravascular ultra-
sound (IVUS) predictors of angiographic in-stent restenosis.
Methods
Patient and lesion demographics. Preinterventional and
postinterventional (post–Palmaz-Schatz stent implantation
plus adjunct balloon angioplasty) IVUS and QCA studies were
performed in 382 lesions in 291 patients for whom follow-up
angiographic data were available 5.5 6 4.8 months (mean 6
SD) later (220 men, 71 women; mean age 61.7 6 10.9 years,
range 30 to 86). Target lesion location was a native coronary
artery in 232 lesions and a saphenous vein graft in 150.
Fourteen native artery lesions were in the left main coronary
artery, 84 in the left anterior descending coronary artery, 40 in
the left circumflex coronary artery and 94 in the right coronary
artery. Nine lesions (2.4%) were total occlusions; 62 (16.2%)
were ostial in location. A total of 476 stents were placed; 295
lesions were treated with a single stent, 80 with two stents and
7 with three stents. Articulated “biliary” stents (PS204) were
used in 121 lesions and “coronary” stents in 261. Of those
lesions treated with coronary stents, 108 stents were 3.0 mm in
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diameter, 86 stents were 3.5 mm in diameter, and 67 stents
were 4.0 mm in diameter.
Stents were implanted according to standard protocols
(5,13). The sheath-based stent delivery system was used to
deliver the coronary stent. Biliary stents were hand-crimped on
conventional coronary or peripheral angioplasty balloons. Op-
erators were not blinded to the IVUS findings during stent
implantation. All stents were implanted with high pressure
adjunct balloon angioplasty (14.5 6 4.5 atm) to achieve
targeted stent expansion. The targeted stent expansion was a
minimal stent cross-sectional area (CSA) $80% of the average
of the proximal and distal reference lumen CSA by IVUS (or
an absolute minimal lumen CSA $7.5 mm2 in native arteries
or $9.0 mm2 in vein grafts) as well as complete stent–vessel
wall apposition. Forty-two lesions were pretreated with
atheroablative devices before stent implantation: 15 lesions
with directional coronary atherectomy (Devices for Vascular
Intervention), 21 with high speed rotational atherectomy
(Heart Technology) and 15 with excimer laser coronary angio-
plasty (Spectranetics/Advanced Interventional Systems).
Patients were studied only after giving written informed
consent; all IVUS studies have the ongoing approval of the
Washington Hospital Institutional Review Board.
Clinical demographics. Baseline clinical demographics
were obtained by independent hospital chart audit performed
by a registered nurse. Angina status was recorded according to
the classification of the Canadian Cardiology Society. Unstable
angina was defined as a recent acceleration of angina, including
pain at rest. A recent myocardial infarction occurred #6 weeks
of the study. A remote myocardial infarction occurred .6 weeks
before the study.
Recorded risk factors for coronary artery disease included
diabetes mellitus (medication dependent only, including oral
hypoglycemic agents and insulin), hypertension (medication
dependent only), hypercholesterolemia (medication depen-
dent or serum cholesterol $240 mg/dl) and smoking (still
smoking or having stopped smoking ,6 months before the
study).
QCA analysis. Qualitative and quantitative coronary an-
giography was performed by an independent core angiographic
laboratory without knowledge of the results of the ultrasound
analysis. Standard qualitative angiographic variables were re-
corded (14). QCA was performed using a computer-assisted,
automated edge-detection algorithm (ARTREK, Quantitative
Cardiac Systems). The external diameter of the contrast-filled
catheter was used as the calibration standard. Minimal lumen
diameter (MLD), reference diameter and percent diameter
stenosis (DS) at end-diastole before and after intervention and
at follow-up were measured from multiple projections, and the
results from the “worst” view were recorded. The target lesion
location was designated as ostial, proximal, mid, distal or
anastomotic (in case of saphenous vein graft lesions). Ostial
lesions began within 3 mm of the major coronary artery ostium.
Lesion length was measured as the distance (in mm) from the
proximal to the distal shoulder of the lesion in the projection
that demonstrated the lesion with the least foreshortening.
Flow was graded according to the Thrombolysis in Myocardial
Infarction (TIMI) study criteria (15).
IVUS imaging protocol. Studies were performed using one
of three commercially available systems. The first system
(CVIS/InterTherapy Inc.) incorporated a single-element 25-
MHz transducer and an angled mirror mounted on the tip of a
flexible shaft that was rotated at 1,800 rpm within a 3.9F short
monorail polyethylene imaging sheath to form planar cross-
sectional images in real time. The second system (CardioVas-
cular Imaging Systems, Inc.) used a 30-MHz single-element
beveled transducer, mounted on the end of a flexible shaft, and
rotated at 1,800 rpm within either a 2.9F long monorail/
common distal lumen imaging sheath or a 3.2F short monorail
imaging sheath. With both systems, the transducer was with-
drawn within the stationary imaging sheath at a speed of 0.5
mm/s using a motorized transducer pullback device. The third
system (Hewlett-Packard and Boston Scientific Corporation)
incorporated a single-element 30-MHz beveled transducer
rotated at 1,800 rpm within a 3.5F short monorail imaging
catheter; with this system the catheter was advanced or with-
drawn manually with fluoroscopic guidance to perform the
imaging sequence.
All IVUS studies were performed after administration of
0.2 mg of intracoronary nitroglycerin. To perform the imaging
sequence, the transducer was positioned ;10 mm beyond the
target lesion or the distal edge of the stent, the motorized
transducer pullback device was activated, and imaging contin-
ued until the transducer reached the aorto-ostial junction.
Quantitative IVUS measurements. Validation of cross-
sectional measurements of external elastic membrane (EEM),
stent, lumen and plaque plus media (P1M) CSAs by IVUS
have been previously reported (16–18). The term EEM is
shorthand for the media–adventitia border, which is a repro-
ducible measure of the total arterial CSA. Because media
thickness cannot be measured accurately, P1M CSA was used
as a measure of the amount of atherosclerotic plaque. The
term cross-sectional narrowing (CSN) has also been called the
plaque burden or percent plaque area by other investigators.
Using computerized planimetry (TapeMeasure, Indec Sys-
tems, Inc.), the target lesion was assessed before intervention
by measuring: 1) EEM CSA (mm2); 2) lumen CSA (mm2); 3)
MLD (mm); 4) P1M CSA (mm2) (equals EEM CSA minus
Abbreviations and Acronyms
CI 5 confidence interval
CSA 5 cross-sectional area
CSN 5 cross-sectional narrowing
DS 5 percent diameter stenosis
EEM 5 external elastic membrane
IVUS 5 intravascular ultrasound
MLD 5 minimal diameter stenosis
OR 5 odds ratio
P1M 5 plaque plus media
QCA 5 quantitative coronary angiography (angiographic)
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lumen CSA); and 5) CSN (%) (equals P1M CSA divided by
EEM CSA).
Acoustic shadowing caused by lesion calcification at times
made identification of the EEM difficult. In these cases,
circumferential or axial extrapolation was used, as previously
described (19,20). When the tissue encompassed the catheter,
the lumen was assumed to be the physical (not acoustical) size
of the imaging catheter. Therefore, 1.0 mm was the smallest
MLD, and 0.8 mm2 was the smallest lumen CSA that could be
measured before intervention.
Target lesion plaque composition was evaluated visually
(21). The presence of significant amounts of calcium, dense
fibrous tissue or soft plaque, as well as dissections at the stent
edges, after intervention was assessed as described previously
(22–24) and tabulated independently for each lesion. The arc
of calcium was measured with a protractor centered on the
lumen (25).
The target lesion was normalized for the reference segment.
Reference segment dimensions were calculated as the mean
value of the proximal and distal reference lumen CSA. For
reference segment, the most normal-looking cross-section
within 10 mm proximal or distal to the target lesion, but before
a major side branch, was selected. If either the proximal or
distal reference segment could not be analyzed (e.g., ostial
lesion location, diffuse disease or major side branch close to
the lesion), then only one reference segment measurement was
used. Cross-sectional reference site measurements were simi-
lar to those made for the target lesion and included the EEM,
lumen, P1M CSA, CSN, MLD and arc of calcification.
The target lesion was also assessed after intervention (after
the last adjunct balloon inflation). Final IVUS measurements
included 1) stent CSA (mm2); 2) lumen CSA (mm2); 3) MLD
(mm); and 4) stent symmetry (minimal stent diameter divided
by maximal stent diameter). Stent expansion was calculated as
the stent CSA divided by the average of the proximal and distal
reference lumen CSAs. Preinterventional and postinterven-
tional IVUS studies were compared to calculate acute lumen
gain (increase in minimal lumen CSA).
Statistics. Statistical analysis was performed using Stat-
View 4.02 (Abacus Concepts) and SAS (SAS Institute, Inc).
Continuous data are presented as mean value 6 SD, and
categoric data are presented as frequencies. Continuous vari-
ables were compared using the Student t test or factorial
analysis of variance (with post hoc analysis using the Fisher
protected least significant difference). Categoric data were
compared using chi-square analysis.
Clinical, procedural, angiographic and IVUS predictors of
the follow-up angiographic results were determined using a
lesion-based assessment. Previous studies have shown that
stented lesions behave independently with regard to restenosis
when multiple lesions are treated in the same patient (26).
Multivariate logistic regression analysis was used to deter-
mine the best predictors of the primary end point: the binary
angiographic definition of restenosis (follow-up QCA DS
$50%) (27). Univariate predictors of angiographic restenosis
with a p value ,0.2 were entered into the multivariate model.
The best independent predictors of restenosis and their 95%
confidence intervals were calculated.
Multivariate linear (or logistic regression) analysis was used
to determine the best predictors of the secondary end points:
1) follow-up QCA MLD, and (2) follow-up QCA DS. Univar-
iate predictors of these secondary end points with a p value
,0.2 were entered into the multivariate model. The best
independent predictors and their correlation coefficients (or
odds ratios for the final models) were calculated.
Results
Univariate clinical predictors of in-stent restenosis. Clini-
cal demographics in the overall cohort were as follows: 76%
were male; 70% had a history of myocardial infarction; 70%
had a history of coronary artery bypass graft surgery; 29% had
unstable angina; 71% had hypertension; and 87% had hyper-
cholesterolemia. Only insulin-dependent diabetes (present in
56 patients, 63% of whom developed restenosis) was a univar-
iate clinical predictor of in-stent restenosis (odds ratio [OR]
2.00, 95% confidence interval [CI] 1.07 to 3.71, p 5 0.0289).
Diabetes treated with oral agents or diet was also tested and
was not found to be significant.
Procedural characteristics as univariate predictors of in-
stent restenosis (Table 1). The number of stents/lesion and
maximal adjunct balloon inflation pressure were univariate
procedural predictors of restenosis. Other procedural vari-
ables, such as “coronary” (vs. “biliary” stent) use and balloon/
artery ratio, were not.
QCA results and angiographic predictors of restenosis.
Preinterventional lesion length measured 9.8 6 6.3 mm. MLD
increased from 1.06 6 0.53 mm before to 2.97 6 0.56 mm after
intervention; DS decreased from 64 6 16% before to 5 6 13%
after intervention. At follow-up, a mean of 5.5 6 4.8 months
after intervention, MLD decreased to 1.56 6 0.82 mm, and DS
increased to 48 6 27%. In this cohort, 191 lesions (50%) were
Table 1. Univariate Procedural Predictors of In-Stent Restenosis
Total
Restenosis
(n 5 191)
No
Restenosis
(n 5 191) OR (95% CI)
p
Value
No. of stents/lesion 1.29 6 0.49 1.33 6 0.51 1.16 6 0.41 2.20 (1.33–3.61) 0.0020
Max inflation pressure (atm) 14.5 6 4.3 15.2 6 4.1 14.0 6 4.4 1.06 (1.07–1.12) 0.0259
Data presented are mean value 6 SD, unless otherwise indicated. CI 5 confidence interval; Max 5 maximal; OR 5
odds ratio.
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restenotic at follow-up. Acute gain was 1.92 6 0.66 mm. The
univariate angiographic predictors of in-stent restenosis are
shown in Table 2.
IVUS results and predictors of restenosis. Minimal lumen
CSA increased from 2.4 6 1.6 mm2 before to 7.6 6 2.5 mm2
after intervention (p , 0.0001). MLD measured by IVUS
correlated with QCA before (r 5 0.476, p 5 0.0001) and after
intervention (r 5 0.503, p , 0.0001). The final stent expansion
measured 83 6 20% of the reference lumen CSA, with a stent
symmetry index of 0.83 6 0.08.
Table 3 shows the univariate IVUS predictors of in-stent
restenosis at a p , 0.05 level. In addition, the preinterventional
P1M CSA was predictive at the p , 0.2 level and was
therefore tested in the multivariate model.
Multivariate predictors of angiographic restenosis (Table
4). Ostial lesion location, IVUS preinterventional lesion site
CSN and IVUS assessment of final lumen dimensions (final
lumen CSA or final MLD) were the most consistent predictors
of the late angiographic results. These three variables pre-
dicted both the primary (binary restenosis) and secondary
(follow-up MLD and follow-up DS) angiographic end points.
There were other predictors of one or two but not all three
of the angiographic end points. The other predictors were as
follows: binary restenosis (IVUS preinterventional EEM CSA
and lumen CSA), follow-up DS (QCA lesion length) and
follow-up MLD (QCA lesion length, preinterventional MLD
and DS and IVUS preinterventional EEM CSA and lumen
CSA). Importantly, postinterventional QCA MLD or DS did
not predict any of the follow-up angiographic end points.
Discussion
Serial IVUS studies have shown that the direction and
magnitude of arterial remodeling are the predominant mech-
anisms for restenosis after balloon or nonstent new device
angioplasty (12). Serial IVUS studies have also shown (10) that
stents prevent negative (or pathologic) vessel remodeling and
that the mechanism of in-stent restenosis is intimal hyperpla-
sia. Thus, predictors of restenosis after stenting procedures
may be different than those after nonstent procedures.
Some of the clinical, procedural and angiographic predic-
tors of restenosis after Palmaz-Schatz stent implantation have
been identified (3,28–31). The Stent Restenosis Study (3)
demonstrated that lesion location, reference vessel diameter
and final MLD were significant predictors of angiographic
MLD at 6 months. In other studies, left anterior descending
coronary artery lesion location (29); stenosis length and initial
lumen gain (30); and multiple stent placement, stenting of
restenotic lesions or chronic total occlusions and suboptimal
angiographic results (31) were related to a higher restenosis
rates. Recent angiographic studies (32,33) have suggested that
increased vessel trauma caused by high pressure adjunct
Table 2. Univariate Angiographic Predictors of In-Stent Restenosis
Total
Restenosis
(n 5 191)
No Restenosis
(n 5 191) OR (95% CI)
p
Value
Ostial location n 5 64 n 5 23 n 5 41 1.82 (1.02–3.23) 0.0425
Ref lumen diam (mm) 3.01 6 0.67 2.85 6 0.66 3.16 6 0.67 0.48 (0.34–0.68) , 0.0001
Lesion length (mm) 9.8 6 6.3 10.5 6 6.6 9.1 6 5.8 1.04 (1.0–1.08) 0.0364
Pre MLD (mm) 1.06 6 0.53 0.96 6 0.50 1.17 6 0.56 0.45 (0.30–0.68) 0.0002
Pre DS (%) 64 6 16 66 6 16 62 6 17 4.58 (1.23–17.01) 0.0232
Final MLD (mm) 2.97 6 0.56 2.84 6 0.57 3.09 6 0.53 0.50 (0.34–0.74) 0.0005
Data presented are mean value 6 SD or number of lesions, unless otherwise indicated. DS 5 diameter stenosis;
MLD 5 minimal diameter stenosis; Pre 5 preintervention; Ref lumen diam 5 reference lumen diameter; other
abbreviations as in Table 1.
Table 3. Univariate Intravascular Ultrasound Predictors of In-Stent Restenosis
Total
(mean 6 SD)
Restenosis
(mean 6 SD)
No Restenosis
(mean 6 SD) OR (95% CI)
p
Value
Ref
EEM CSA (mm2) 16.5 6 6.2 15.5 6 5.0 17.7 6 7.1 0.94 (0.90–0.98) 0.0028
Lumen CSA (mm2) 9.4 6 3.6 8.7 6 3.0 10.1 6 4.1 0.88 (0.82–0.95) 0.0010
Lesion site
Pre EEM CSA (mm2) 17.1 6 7.3 15.9 6 6.6 18.6 6 8.1 0.95 (0.91–0.99) 0.0176
Pre lumen CSA (mm2) 2.4 6 1.6 2.0 6 1.3 2.7 6 1.8 0.74 (0.61–0.90) 0.0029
Pre MLD (mm) 1.42 6 0.40 1.33 6 0.34 1.51 6 0.45 0.32 (0.15–0.66) 0.0022
Pre CSN (%) 85.4 6 7.5 86.7 6 6.8 84.3 6 8.3 60.27 (1.29–1.92) 0.0367
Final lumen CSA (mm2) 7.6 6 2.5 7.1 6 2.1 8.1 6 2.8 0.847 (0.76–0.94) 0.0014
Final MLD (mm) 2.74 6 0.49 2.79 6 0.55 2.67 6 0.42 0.51 (0.31–0.84) 0.0080
CSA 5 cross-sectional area; CSN 5 cross-sectional narrowing; EEM 5 external elastic membrane; other
abbreviations as in Tables 1 and 2.
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balloon inflations may induce more late lumen loss and even a
higher restenosis rate. Higher restenosis rates have also been
found in diabetic patients (34).
Previous IVUS studies of in-stent restenosis. IVUS has
been used for optimizing stent deployment, resulting in im-
proved stent expansion, stent apposition and final lumen
dimensions (5,6); however, there are few data on IVUS
predictors of in-stent restenosis. In three IVUS studies (35–
37), the final lumen dimensions (either MLD or CSA) were
important predictors of long-term results (either angiographic
restenosis or target vessel revascularization). In two of these
studies (35,36), the absolute dimensions were more significant
predictors than the relative stent expansion (defined as the
stent/reference lumen ratio). Another analysis from one of
these studies (38) showed that stent symmetry (ratio of mini-
mal to maximal stent dimensions) was also a predictor of target
vessel revascularization.
Restenosis in lesions treated with Palmaz-Schatz stents has
been found to occur more frequently at the central articulation
of the stent. The reasons for this pattern of restenosis have
been analyzed and include both acute tissue prolapse (causing
smaller final lumen dimensions at the central articulation) and
exaggerated neointimal proliferation (10,11). Special attention
has also been focused on restenosis at the margins of Palmaz-
Schatz stents (39), showing the importance of the plaque
burden at the reference site.
Univariate predictors of in-stent restenosis. In the current
study, there were a number of univariate predictors of in-stent
restenosis that were eliminated from the multivariate model.
However, some of these univariate predictors are still worthy
of comment. Insulin-dependent diabetes mellitus was associ-
ated with a higher restenosis rate, in agreement with recent
studies (34,40) indicating that diabetes mellitus results in
exaggerated late lumen loss due to more intimal hyperplasia in
stented lesions. Although insulin-treated diabetes mellitus
increased restenosis in the current study, non–insulin-treated
diabetic patients appeared to be more similar to nondiabetic
patients.
Lesion length and number of deployed stents were both
univariate predictors of restenosis and has been reported
before by numerous investigators, including Haude et al. (41),
Ellis et al. (31) and Kastrati et al. (28). Longer lesions tend to
be treated with more stents. However, both lesion length and
number of stents were eliminated from the multivariate mod-
els, suggesting that length may be less important than final
lumen dimensions.
Angiographic and IVUS reference dimensions were univar-
iate predictors of the follow-up angiographic results, but were
also eliminated from the multivariate models. Like length
measurements, the importance of reference dimensions may
be reduced by maximizing final lumen dimensions (35,36).
Adjunct balloon inflation pressures were also found to be a
univariate predictor of in-stent restenosis, in agreement with
recent reports (32,33). However, the interrelation among
adjunct balloon angioplasty inflation pressures (necessary to
optimize stent implantation), vessel size, final lumen dimen-
sions, stent design and mechanics and lesion and plaque
characteristics have yet to be determined.
Multivariate predictors of in-stent restenosis. In the cur-
rent study there were three variables that predicted both the
primary angiographic end point and all three secondary angio-
graphic end points. These variables were ostial lesion location,
preinterventional IVUS lesion site plaque burden and postint-
ervention IVUS lumen dimensions.
Ostial lesion location was a multivariate predictor of in-stent
restenosis. Ostial lesions commonly recur after balloon angio-
plasty, which has in part, been attributed to suboptimal acute
procedural results. Although acute results have improved
during the era of new device angioplasty (particularly with
stent implantation), one recent study (42) has shown that there
may be an exaggerated neointimal hyperplastic response within
Table 4. Multivariate Predictors of Follow-Up Angiographic Results (restenosis, diameter stenosis, late
lumen loss and minimal lumen diameter)
Restenosis F/U DS F/U MLD
OR (95% CI)
p
Value
Corr
Coeff
p
Value
Corr
Coeff
p
Value
Ostial location 4.01 (1.31–12.29) 0.0151 0.1823 0.0033 20.4814 0.0177
QCA
Lesion length 0.0087 0.0086 20.0238 0.0298
Pre MLD 0.8612 0.0130
Pre DS 1.7565 0.0971
IVUS lesion
Pre lumen CSA 2.58 (1.06–6.28) 0.0368 20.2592 0.0472
Pre EEM CSA 0.83 (0.72–0.95) 0.0088 0.0429 0.0303
Pre CSN 1.25 (1.06–1.47) 0.0088 0.9037 0.0049 26.3529 0.0136
Final lumen CSA 0.1419 0.0002
Final MLD 0.24 (0.08–0.74) 0.0136 20.1270 0.0153
Corr Coeff 5 correlation coefficient; F/U 5 follow-up; IVUS 5 intravascular ultrasound; QCA 5 quantitative
coronary angiography; other abbreviations as in Tables 1 to 3.
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stents implanted into the aorto-ostial location compared with
stents implanted in other locations.
Plaque burden before stent placement was a multivariate
predictor of in-stent restenosis. Although lumen dimensions
after stent placement can be optimized by deliberate use of
high pressure inflations and oversized balloons (equalizing the
acute postprocedural results for different preprocedural lesion
substrates), only atheroablation can reduce plaque burden
before stent placement. The mechanism by which plaque
burden is related to restenosis is not clear. A number of
explanations are possible. An excessive preinterventional
plaque burden may limit stent expansion, necessitating aggres-
sive adjunct balloon angioplasty to optimize stent dimensions,
which could aggravate deep vessel wall trauma. Alternatively,
the atherosclerotic plaque may be the source of the cells
involved in the intimal hyperplastic process. Two recent re-
ports (43,44) (one using high speed rotational atherectomy and
one using directional coronary atherectomy) have shown su-
perior acute and long-term results compared with stent place-
ment alone.
Finally, IVUS postintervention lumen dimensions were an
independent predictor of in-stent restenosis. Previous studies
(45) have shown that the postinterventional lumen dimensions
are the strongest predictors of restenosis, regardless of device
use. In the current study, IVUS measures of postinterventional
lumen dimensions (whether MLD or minimal lumen CSA)
were stronger predictors of in-stent restenosis than QCA
measurement of lumen dimensions. As shown in this and other
studies, QCA has a limited ability to measure lumen dimen-
sions accurately after stent placement; the correlation between
the QCA and IVUS measurement of MLD in the current study
was only fair.
Limitations of the study. There are a number of limitations
to this study: 1) Although this was an inclusive series of lesions
(and patients) studied before and after intervention and at
follow-up, there was a potential for selection bias because of
the reason for angiographic and IVUS follow-up (e.g., recur-
rent chest pain). As a result, the number of lesions that were
restenotic at follow-up was high. However, because IVUS is
routinely used for almost all stent procedures in our labora-
tory, there should not have been a bias in selecting lesions for
imaging before or after stenting. 2) The operator was not
blinded to the IVUS images; to the contrary, the ultrasound
information was used to optimize the acute procedural results.
Although use of IVUS for stent deployment has been recom-
mended (5,6), this is by far not common practice. Thus, results
might have been different for patients treated with angio-
graphic guidance alone. 3) Most of the lesions were treated
with a single stent, whereas the number of lesions treated with
two or more stents was relatively small. 4) These findings may
not apply to all stents. 5) The present study was not able to
identify whether ablative therapy before stent placement had
an impact on the development of in-stent restenosis. Several
devices were used before stent placement; however, the abso-
lute number of lesions treated with ablative techniques before
stent placement was small. 6) The ability to identify clinical,
procedural, angiographic or IVUS predictors for in-stent re-
stenosis does not mean that an interventional approach mod-
ifying these variables will reduce the restenosis rate; this will
need to be studied prospectively in randomized trials.
Conclusions. Ostial lesion location and IVUS preinterven-
tional plaque burden and postinterventional lumen dimensions
were the most consistent predictors of angiographic in-stent
restenosis. These findings were more consistent predictors of
in-stent restenosis than other clinical or angiographic variables.
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